As part of the Oxford Kafka 2024 celebrations, a series of events exploring Franz Kafka’s contributions to literature, arts, culture and society, Oxford Health Biomedical Research Centre (BRC) supported a…
New research, supported by our BRC Molecular Targets’ Theme Co-Leads Professors Paul Harrison and Rachel Upthegrove and BRC Dementia Theme Co-Lead Professor Masud Husain, has found that patients who were…
Recently, the NIHR Oxford Health Clinical Research Facility (OH CRF) has begun researching a new potential drug treatment for Treatment-Resistant Depression (TRD). A significant number of people with depression are not…
We would like to congratulate our esteemed colleague Professor Rachel Upthegrove MBE, MBBS, FRCPsych, PhD on her recent achievement of receiving the Member of the Order of the British Empire…
Clare Mackay, National Institute for Health and Care Research (NIHR) Oxford Health Biomedical Research Centre (OH BRC) Dementia Theme Lead and Professor of Imaging Neuroscience at the University of Oxford,…
The New Therapeutic Approaches in Translational Mental Health Conference was held on 16 September 2024 at the Mathematical Institute in Oxford. The event was organised by Betina Nair and Dr…
NIHR Oxford Health Biomedical Research Centre (OH BRC) and NIHR Oxford Biomedical Research Centre are seeking committed individuals to join their Diversity in Research Group to share experiences and ideas…
Researchers from our BRC Data Science Theme have contributed to an article on the use of Electronic Health Records (EHRs) to facilitate personalised treatments for psychiatric conditions. Clinical prediction models…
This week, a product licence for the medicine lecanemab (Leqembi) was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to treat adult patients in the early stages of…
Research supported by University of Oxford’s Department of Experimental Psychology Prof. Anke Ehlers, Theme Lead of the BRC’s Psychological Treatments Theme, has found that the type of coping strategy used…
Oxford will host the first conference of its kind into body-focused repetitive behaviours (BFRBs) such as hair pulling and skin picking next month. It comes just over a year after…
A prescription treatment for insomnia developed by Big Health has received US Food and Drug Administration (FDA) approval this week. Big Health joint co-founder University of Oxford’s Prof Colin Espie…
Increasing serotonin can change how people learn from negative information, as well as improving how they respond to it, according to a new study published in the leading journal Nature…
In a new paper published today in BJPsych it is suggested that a specific anti constipation drug, prucalopride may reduce the risk of experiencing depression in individuals with no past…
Many people who were hospitalised with COVID-19 continue to have cognitive and psychiatric problems even two to three years post-infection, according to a new study published today in Lancet Psychiatry….
Oxford University announces four new online therapies for anxiety and PTSD, now available on the NHS. The therapies target childhood anxiety and post-traumatic stress disorders and were developed with support form…
Researchers from the Biomedical Research Centre’s Preventing Multiple Morbidities Theme are looking into whether a ketogenic diet is an effective treatment for treatment-resistant depression (TRD). A ketogenic diet consists of…
A study into Alzheimer’s disease, completed by researchers in the BRC’s Dementia Theme, has found that data gathered from online cognition testing correlates to protein blood biomarker levels associated with…
The new recombinant shingles vaccine ‘Shingrix’ is associated with a reduced risk of dementia compared to an earlier shingles vaccine, according to a major new study published in Nature Medicine….
Researchers from the BRC’s Psychological Treatments Theme have contributed to a recent article on the programming characteristics of VR characters and their interpretations by people with paranoia. Paranoia, when a…
